Close Menu

A Swig of Bacteria

A number of companies are working toward using genetically modified bacteria to treat disease, NPR reports.

"This is a really exciting new modality that allows us to think about therapies in a new way and really look at diseases in a whole new way: A living medicine that can respond to its environment," Caroline Kurtz, a researcher at Synlogic, tells NPR.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The US Patent and Trademark Office is opening another interference proceeding in the CRISPR patent fight.

There's increasing genetic evidence that a number of ancient hominins may have contributed to the human gene pool, according to Discover's The Crux blog.

The Japan News writes that Japan needs to seize the opportunity to ensure that a wide number of people benefit from personalized cancer treatments.

In Cell this week: messenger RNA expression and translation, RNA localization atlas, and more.